Literature DB >> 10884044

Vestibular compensation modifies the sensitivity of vestibular neurones to inhibitory amino acids.

N Vibert1, M Beraneck, A Bantikyan, P P Vidal.   

Abstract

The progressive disappearance of the postural and oculomotor syndrome triggered by unilateral labyrinthectomy (vestibular compensation) is a model of plasticity in the adult central nervous system. This recovery may involve modifications of the pharmacological profile of central vestibular neurones, in particular their sensitivity to inhibitory amino acids. We therefore compared the sensitivity of medial vestibular nucleus neurones to glycine and muscimol in slices taken either from control animals, or from guinea-pigs labyrinthectomized 3 days before. We demonstrate that the loss of excitatory inputs experienced by the ipsilesional vestibular neurones induces a decrease in their sensitivity to inhibitory amino acids. These pharmacological changes should facilitate the recovery of a normal balance between the average resting discharge of neurones in both vestibular nuclei.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10884044     DOI: 10.1097/00001756-200006260-00023

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  20 in total

1.  Plasticity of spontaneous excitatory and inhibitory synaptic activity in morphologically defined vestibular nuclei neurons during early vestibular compensation.

Authors:  Mei Shao; June C Hirsch; Kenna D Peusner
Journal:  J Neurophysiol       Date:  2011-09-28       Impact factor: 2.714

2.  GABA(A) receptor subunit expression in the guinea pig vestibular nucleus complex during the development of vestibular compensation.

Authors:  Catherine M Gliddon; Cynthia L Darlington; Paul F Smith
Journal:  Exp Brain Res       Date:  2005-07-14       Impact factor: 1.972

3.  Asymmetric recovery in cerebellar-deficient mice following unilateral labyrinthectomy.

Authors:  M Beraneck; J L McKee; M Aleisa; K E Cullen
Journal:  J Neurophysiol       Date:  2008-05-28       Impact factor: 2.714

4.  Role of the flocculus in mediating vestibular nucleus neuron plasticity during vestibular compensation in the rat.

Authors:  Alex R Johnston; Jonathan R Seckl; Mayank B Dutia
Journal:  J Physiol       Date:  2002-12-15       Impact factor: 5.182

5.  The mammalian efferent vestibular system plays a crucial role in vestibulo-ocular reflex compensation after unilateral labyrinthectomy.

Authors:  Patrick P Hübner; Serajul I Khan; Americo A Migliaccio
Journal:  J Neurophysiol       Date:  2017-01-11       Impact factor: 2.714

6.  Long-term deficits in motion detection thresholds and spike count variability after unilateral vestibular lesion.

Authors:  Xiong-Jie Yu; Jakob S Thomassen; J David Dickman; Shawn D Newlands; Dora E Angelaki
Journal:  J Neurophysiol       Date:  2014-05-21       Impact factor: 2.714

7.  BK Channels Are Required for Multisensory Plasticity in the Oculomotor System.

Authors:  Alexandra B Nelson; Michael Faulstich; Setareh Moghadam; Kimberly Onori; Andrea Meredith; Sascha du Lac
Journal:  Neuron       Date:  2016-12-15       Impact factor: 17.173

8.  Histaminergic and glycinergic modulation of GABA release in the vestibular nuclei of normal and labyrinthectomised rats.

Authors:  Filip Bergquist; Alasdair Ruthven; Mike Ludwig; Mayank B Dutia
Journal:  J Physiol       Date:  2006-10-12       Impact factor: 5.182

9.  An in situ hybridization and immunofluorescence study of GABA(A) and GABA(B) receptors in the vestibular nuclei of the intact and unilaterally labyrinthectomized rat.

Authors:  Lyndell Eleore; Isabelle Vassias; Isabelle Bernat; Pierre-Paul Vidal; Catherine de Waele
Journal:  Exp Brain Res       Date:  2004-09-25       Impact factor: 1.972

10.  Amino acid transporter (VIAAT, VGLUT2) and chloride cotransporter (KCC1, KCC2 and NKCC1) expression in the vestibular nuclei of intact and labyrinthectomized rat.

Authors:  Lyndell Eleore; Mohamed Reza Ardehali; Isabelle Vassias; Pierre-Paul Vidal; Catherine de Waele
Journal:  Exp Brain Res       Date:  2007-06-28       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.